Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway

[1]  M. Regan,et al.  Association of cystic fibrosis with abnormalities in fatty acid metabolism. , 2004, The New England journal of medicine.

[2]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[3]  J. Bousquet,et al.  Lipoxin A4 Stimulates a Cytosolic Ca2+Increase in Human Bronchial Epithelium* , 2003, The Journal of Biological Chemistry.

[4]  B. Aronow,et al.  Transcriptional Adaptation to Cystic Fibrosis Transmembrane Conductance Regulator Deficiency* , 2003, The Journal of Biological Chemistry.

[5]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[6]  C. Serhan.  Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. , 2002, Prostaglandins & other lipid mediators.

[7]  M. Schluchter,et al.  Murine models of chronic Pseudomonas aeruginosa lung infection , 2002, Laboratory animals.

[8]  J. Bousquet,et al.  Lipoxins are potential endogenous antiinflammatory mediators in asthma. , 2002, American journal of respiratory and critical care medicine.

[9]  A. Young,et al.  Lipoxin A4 Analogs Attenuate Induction of Intestinal Epithelial Proinflammatory Gene Expression and Reduce the Severity of Dextran Sodium Sulfate-Induced Colitis1 , 2002, The Journal of Immunology.

[10]  T. Noah,et al.  Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[11]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[12]  C. Serhan,et al.  Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[13]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[14]  J. Costerton.  Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. , 2001, Trends in microbiology.

[15]  D. Radzioch,et al.  Mouse models of chronic lung infection with Pseudomonas Aeruginosa: Models for the study of cystic fibrosis , 2000, Pediatric pulmonology.

[16]  S. Freedman,et al.  Fatty acids in cystic fibrosis , 2000, Current opinion in pulmonary medicine.

[17]  C. Clish,et al.  Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.

[18]  S. de Bentzmann,et al.  Inflammation and infection in naive human cystic fibrosis airway grafts. , 2000, American journal of respiratory cell and molecular biology.

[19]  M. Sanak,et al.  Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. , 2000, The European respiratory journal.

[20]  C. Clish,et al.  Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Chambers,et al.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. , 1999, Molecular pharmacology.

[22]  Jilly F. Evans,et al.  Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.

[23]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[24]  C. Serhan,et al.  Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. , 1998, The Journal of clinical investigation.

[25]  C. Serhan,et al.  Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release , 1998, The Journal of experimental medicine.

[26]  T. Noah,et al.  Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. , 1997, The Journal of infectious diseases.

[27]  U. Höpken,et al.  The C5a chemoattractant receptor mediates mucosal defence to infection , 1996, Nature.

[28]  P. Henson.  A complement to host defence , 1996, Nature.

[29]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[30]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[31]  M. Konstan,et al.  Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. , 1993, The American review of respiratory disease.

[32]  R. Crystal,et al.  Aerosol α1 -antitrypsin treatment for cystic fibrosis , 1991, The Lancet.

[33]  N. Krinsky,et al.  Quantitative determination of myeloperoxidase using tetramethylbenzidine as substrate. , 1982, Analytical biochemistry.

[34]  A. Verkman,et al.  Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. , 2003, American journal of physiology. Cell physiology.

[35]  C. Serhan,et al.  Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. , 2001, The American journal of pathology.

[36]  B. Levy,et al.  Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. , 2000, Ernst Schering Research Foundation workshop.

[37]  T. Noah,et al.  Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. , 1999, American journal of respiratory and critical care medicine.

[38]  J. Pilewski,et al.  Role of CFTR in airway disease. , 1999, Physiological reviews.